Home › Medicines › Inj. K MM
বাংলায় দেখুন
Inj. K MM

Inj. K MM

Injection

🧬 Phytomenadione 🏢 Incepta Pharmaceuticals Ltd.
Generic Name Phytomenadione
Manufacturer Incepta Pharmaceuticals Ltd.
Unit Price 10 mg ampoule: ৳ 45.86 (1 x 5: ৳ 229.30)

🔹 Indications

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔹 Pharmacology

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔹 Dosage & Administration

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔹 Interaction

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔹 Contraindications

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔹 Side Effects

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔹 Precautions & Warnings

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔹 Storage Conditions

Inj. K MM (Vitamin K-1) is indicated in following indications-
  • Prophylaxis and treatment of haemorrhagic disease in the newborn.
  • Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
  • Prevention and treatment of bleeding due to vitamin K deficiency.

🔍 People also search for

Inj. K MM Inj. K MM Injection used for Inj. K MM side effects Inj. K MM price Inj. K MM dose Inj. K MM Injection uses Is Inj. K MM safe Inj. K MM dosage Inj. K MM alternative Inj. K MM Bangladesh Phytomenadione Phytomenadione price Bangladesh Injection price Bangladesh Incepta Pharmaceuticals Ltd. medicine bd

💡 Frequently Asked Questions

Inj. K MM (Vitamin K-1) is indicated in following indications- Prophylaxis and treatment of haemorrhagic disease in the newborn. Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VI...
Inj. K MM (Vitamin K-1) is indicated in following indications- Prophylaxis and treatment of haemorrhagic disease in the newborn. Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VI...
Inj. K MM (Vitamin K-1) is indicated in following indications- Prophylaxis and treatment of haemorrhagic disease in the newborn. Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VI...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review

Alternative Medicines
(Same Generic)

Babykion Injection

Chemist Laboratories Ltd.

2 mg ampoule: ৳ 20.00 (1 x 5: ৳ 100.00)

Dinakion Injection

Drug International Ltd.

10 mg ampoule: ৳ 45.15 (1 x 5: ৳ 225.75)

Inj. K MM Injection

Incepta Pharmaceuticals Ltd.

2 mg ampoule: ৳ 19.89 (1 x 5: ৳ 99.45)

Dinakion MM Injection

Drug International Ltd.

2 mg ampoule: ৳ 19.99 (1 x 5: ৳ 99.95)

K-One MM Injection

Square Pharmaceuticals PLC

2 mg ampoule: ৳ 19.94 (2 x 3: ৳ 119.64)

Konakion Injection

Radiant Pharmaceuticals Ltd.

2 mg ampoule: ৳ 98.00 (1 x 5: ৳ 490.00)

Konakion Injection

Radiant Pharmaceuticals Ltd.

10 mg ampoule: ৳ 102.00 (1 x 5: ৳ 510.00)